0.25 / AMA PRA Category 1 Credit(s)TM 0.25 / CE for Pharmacists (0.025 CEUs)
Provided by MediCom Worldwide, Inc.
Supported by Teva Pharmacuticals
Review and participate in this clinical discussion between a patient and her primary care provider as they explore options for achieving optimal pain control of her migraine headaches.
Primary care providers who are physicians, pharmacists, and physician assistants who provide care to patients with migraine
After completing this activity, the participant should be better able to:
Identify patients who are candidates for preventive treatment through effective questioning and assessment of migraine frequency and severity
List current and emerging pharmacologic treatment options designed to reduce the frequency and severity of migraine attacks
Conflict Of Interest Disclosure Policy
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Contributing Author Susan L. Hutchinson, MD Director and Founder Orange County Migraine & Headache Center Irvine, CA
The individual listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.
Peer Reviewer Disclosure
In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Pharmacists
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity is acceptable for 0.25 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-17-148-H01-P. Knowledge-based CPE activity.
In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Dr. Hutchinson has indicated that he does not intend to discuss off-label uses of drugs, mechanical devices, biologics or diagnostics approved by the US Food and Drug Administration (FDA) for use in the US. Dr. Hutchinson has indicated that he does not intend to discuss investigational drugs, mechanical devices, biologics or diagnostics not approved by the FDA for use in the US.
This activity is eligible for credit through May 10, 2018. After this date, this activity will expire and no further credit will be awarded.
—Read the target audience, learning objectives, and faculty disclosures. —You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity. —Complete the educational content as designed. —Complete the post-test. To receive a certificate, you must receive a passing score of 70%. —Complete the activity evaluation survey to provide feedback and information useful for future programming. —Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.